AI Tools
PathExplore
PathExplore : prix, capacités, mises à jour et alternatives, lus sur les pages de l’éditeur.

En anglais
Key facts
- Price
- Price on request Read on pathai.com
- Free plan
- Not stated on the maker’s pages
- Platforms
- Web
- API
- Not stated on the maker’s pages
- Open source
- Not stated on the maker’s pages
- Last update
- 28 Jul 2026 Read on pathai.com
- Prices checked
- 19 Nov 2026 Read on pathai.com
PathExplore uses AI to identify cells and tissue regions in H&E whole-slide images and produce standardized measurements of the tumor microenvironment, including cell counts and spatial distributions. PathAI describes more than 600 human-interpretable features per sample and makes the outputs available through its AISight platform.
It is intended for translational and biomarker research, not diagnosis. PathAI says access to PathExplore features for publicly available TCGA slides is free for academic researchers; non-academic access to that data is licensed. Pricing for other use is not listed on the product page.
- Category
- Research & Education
- Read from the maker’s pages
- 2026-11-18
Company
Features
- Segments, detects, and classifies cells across H&E whole-slide images
- Produces more than 600 human-interpretable features per sample
- Measures cell counts and spatial distributions across tissue regions
- Includes features tailored to cancer indications and pan-tumor analyses
- Supports exploration of immune phenotypes and tertiary lymphoid structures
- Provides PathExplore outputs through the AISight research platform
- For research use only; not for diagnostic procedures
Use cases
- Explore tumor microenvironment patterns across cancer cohorts
- Identify histological biomarkers linked to therapeutic response
- Compare AI-derived tissue features with molecular data
- Quantify lymphocyte density and distribution in tumor tissue
- Improve measurement of established biomarkers and disease signatures
Pricing
Price on request
- Prices checked
- 2026-11-19
PathExplore (Enterprise / Custom)
price on request
- AI-powered panel of >600 human interpretable features (HIFs) for spatial TME characterization from H&E WSIs
- Single-cell resolution analysis across 14 cancer indications
- Self-service integration on AISight (early access for select academic medical centers)
- PathExplore Data Access Program: free HIFs from TCGA for academic researchers (license for non-academic)
Latest updates
- PathAI Advances AISight® Dx with the v2.21 Release: Intelligent Dashboard Controls, Enhanced Data Organization, & Enterprise-Scale Configur…
AISight Dx adds intelligent dashboard controls, enhanced data organization, and enterprise-scale configurability.
- PathAI’s AISight® Dx IMS Platform Supports the AISight Consults Workflow for Streamlined Digital Consult Management
AISight Dx IMS supports AISight Consults for digital case submission, review, collaboration, and reporting.
- PathAI Advances AISight® Dx with the v2.20 Release: Enhancing Viewer Usability, Workflow Efficiency, and Platform Reliability
AISight Dx updates viewer usability, workflow efficiency, and platform reliability.
- PathAI Expands AISight® Dx with the v2.19 Release: Enhancing Flexibility, Collaboration, Reporting and Workflow Precision
AISight Dx updates flexibility, collaboration, reporting, and workflow precision.
- PathAI Expands AISight® Clinical Trials Platform with Launch of AIM-HI™ UC and IBDExploreTM for Standardized Histopathology Endpoints
IBDExplore launched on the AISight Clinical Trials Platform alongside AIM-HI UC for standardized histopathology endpoints.
Where it works
Web
More from PathAI
- AISight
Cloud-based digital pathology platform for managing slide images and AI-assisted reads in clinical trials.
Questions about PathExplore
How much does PathExplore cost?
The plans on the maker’s pricing page: PathExplore (Enterprise / Custom) (price on request). Prices checked on 19 Nov 2026.
Which platforms does PathExplore run on?
PathExplore runs on Web, as its maker’s pages state. Read on the maker’s pages on 18 Nov 2026.
Is PathExplore still available?
Yes, as of 18 Nov 2026: its maker’s pages were read that day and carried no notice that PathExplore has ended.
What changed recently in PathExplore?
The latest entry in its maker’s changelog: 28 Jul 2026, “PathAI Advances AISight® Dx with the v2.21 Release: Intelligent Dashboard Controls, Enhanced Data Organization, & Enterprise-Scale Configur…”. Before it: 14 May 2026, “PathAI’s AISight® Dx IMS Platform Supports the AISight Consults Workflow for Streamlined Digital Consult Management”. Changelog checked on 17 Nov 2026.
Sources
- https://www.pathai.com/pathexplore — Product capabilities, AISight delivery, research-only limitation, and free academic access to TCGA-associated features; no commercial price list shown.
- https://www.pathai.com/request-a-path-explore-demo — Confirms the product description and research-only limitation.
- https://www.pathai.com/news/pathai-announces-self-service-integration-of-pathexplore-on-aisight-to-advance-tumor-microenvironment-analysis — PathAI's announcement of early access through AISight, dated November 18, 2025.
Not confirmed
- Prices
- no official PathExplore pricing page was found in the search; the product page gives no commercial tier prices.
- no official tier prices or billing terms were listed.
- no paid starting price was listed; free academic access applies only to the specified TCGA-associated data.
- Free plan
- the free academic data access program is not described as a general product tier.
- API
- the pages reviewed do not confirm an API.
- Open source
- the pages reviewed do not specify an open-source status or license.
- Platforms
- web access is described through AISight; other platform availability was not confirmed.
- Latest version
- no PathExplore product version or current model name was identified.